| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.664 | 0.004 | 0.821 | Cyclooxygenase 1 inhibitor | 0.821 0.003 DBMET00304 | DBMET00304 | |
| 0.692 | 0.032 | 0.692 | Antiinflammatory | 0.595 0.055 DBMET00304 | ||
| 0.495 | 0.051 | 0.517 | Analgesic | 0.517 0.045 DBMET00304 | DBMET00304 | |
| 0.449 | 0.005 | 0.558 | Cyclooxygenase inhibitor | 0.558 0.004 DBMET00304 | DBMET00304 | |
| 0.402 | 0.013 | 0.402 | Non-steroidal antiinflammatory agent | 0.24 0.047 DBMET00304 | ||
| 0.305 | 0.013 | 0.381 | Cyclooxygenase 2 inhibitor | 0.381 0.006 DBMET00304 | DBMET00304 | |
| 0.353 | 0.08 | 0.353 | Toll-Like receptor 7 agonist | |||
| 0.28 | 0.017 | 0.28 | MAO A inhibitor | 0.167 0.037 DBMET00304 | ||
| 0.345 | 0.085 | 0.345 | Toll-Like receptor agonist | |||
| 0.295 | 0.047 | 0.295 | 5 Hydroxytryptamine uptake stimulant | 0.269 0.064 DBMET00304 | ||
| 0.235 | 0.031 | 0.235 | MAO inhibitor | 0.15 0.06 DBMET00304 | ||
| 0.256 | 0.06 | 0.256 | Calpain inhibitor | |||
| 0.267 | 0.089 | 0.267 | Lipoxygenase inhibitor | 0.225 0.117 DBMET00304 | ||
| 0.214 | 0.081 | 0.214 | RNA-directed DNA polymerase inhibitor | |||
| 0.201 | 0.069 | 0.201 | Focal adhesion kinase 2 inhibitor | |||
| 0.134 | 0.015 | 0.134 | Prostaglandin-E synthase inhibitor | |||
| 0.135 | 0.019 | 0.135 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.145 | 0.039 | 0.145 | MAO B inhibitor | 0.092 0.064 DBMET00304 | ||
| 0.167 | 0.063 | 0.167 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.139 | 0.041 | 0.139 | CC chemokine 6 receptor antagonist | 0.128 0.08 DBMET00304 | ||
| 0.236 | 0.138 | 0.236 | Transcription factor NF kappa B inhibitor | |||
| 0.103 | 0.011 | 0.103 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.099 0.012 DBMET00304 | ||
| 0.181 | 0.093 | 0.181 | Pyruvate kinase inhibitor | |||
| 0.157 | 0.082 | 0.157 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.206 | 0.15 | 0.206 | Nootropic | |||
| 0.057 | 0.007 | 0.057 | MAP3K5 inhibitor | |||
| 0.068 | 0.023 | 0.068 | Elastase inhibitor | 0.065 0.026 DBMET00304 | ||
| 0.081 | 0.043 | 0.081 | Histone deacetylase stimulant | |||
| 0.081 | 0.043 | 0.081 | Histone deacetylase SIRT1 stimulant | |||
| 0.159 | 0.123 | 0.159 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.128 | 0.094 | 0.128 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.131 | 0.102 | 0.131 | Hexokinase inhibitor | |||
| 0.098 | 0.069 | 0.098 | MAP kinase kinase kinase inhibitor | |||
| 0.034 | 0.011 | 0.034 | Protocollagen prolyl hydroxylase inhibitor | 0.031 0.014 DBMET00304 | ||
| 0.152 | 0.134 | 0.152 | Dyrk kinase inhibitor | |||
| 0.175 | 0.159 | 0.175 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.067 | 0.054 | 0.067 | Secretase beta inhibitor | |||
| 0.025 | 0.018 | 0.025 | 5 Hydroxytryptamine 1F agonist | |||
| 0.163 | 0.162 | 0.163 | Peptidyltransferase inhibitor | |||
| 0.031 | 0.03 | 0.031 | Calpain 1 inhibitor | |||
| 0.029 | 0.035 | 0.038 | Nicotinic acid receptor agonist | 0.038 0.023 DBMET00304 | DBMET00304 | |
| 0.028 | 0.039 | 0.127 | Nicotinic acid receptor 2 agonist | 0.127 0.005 DBMET00304 | DBMET00304 | |
| 0.034 | 0.055 | 0.041 | VCAM-1 antagonist | 0.041 0.023 DBMET00304 | DBMET00304 | |
| 0.034 | 0.056 | 0.04 | VCAM antagonist | 0.04 0.024 DBMET00304 | DBMET00304 | |
| 0.019 | 0.081 | 0.05 | Urokinase inhibitor | 0.05 0.032 DBMET00304 | DBMET00304 | |
| 0.069 | 0.312 | 0.174 | Sphingosine 1-phosphate receptor 2 agonist | 0.174 0.016 DBMET00304 | DBMET00304 | |
| 0.034 | 0.362 | 0.123 | Mcl-1 antagonist | 0.123 0.121 DBMET00304 | DBMET00304 | |
| 0.056 | 0.408 | 0.221 | Thioredoxin glutathione reductase inhibitor | 0.221 0.154 DBMET00304 | DBMET00304 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |